HIV and bone disease: A perspective of the role of microRNAs in bone biology upon HIV infection

Journal of Osteoporosis

Volumn 2013, Issue , 2013, Pages

  Del Carpio Cano, Fabiola E ^a   Dela Cadena, Raul A ^a   Sawaya, Bassel E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ANTIRETROVIRUS AGENT; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; DICKKOPF 1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FAS LIGAND; HISTONE DEACETYLASE 5; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR; PROTEIN V MAF; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA2; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; WNT PROTEIN;

ALCOHOL CONSUMPTION; BONE DEVELOPMENT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENCHONDRAL OSSIFICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAMEMBRANOUS OSSIFICATION; LONGITUDINAL STUDY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SMOKING;

EID: 84888871563     PISSN: 20908059     EISSN: 20420064     Source Type: Journal    
DOI: 10.1155/2013/571418     Document Type: Review

References (104)

1. Division of HIV/AIDS Prevention, CDC, National Center for HIV/AIDS VH, STD and TB Prevention, HIV in the United States: At a Glance 2012
2. McNeil D. G. Jr., After marrow transplants, 2 more patients appear H.I.V.-free without drugs. New York Times July 2013. http://www.nytimes.com/ 2013/07/04/health/post-transplant-and-off-drugs-hiv-patients-are-apparently- virus-free.html?-r=1
3. Hutter G., Nowak D., Mossner M., Ganepola S., Müß A., Allers K., Schneider T., Hofmann J., Külcherer C., Blau O., Blau I. W., Hofmann W. K., Thiel E., Long-term control of HIV by CCR5 delta32/delta32 stem-cell transplantation. The New England Journal of Medicine 2009 360 7 692 698 2-s2.0-60549090253 10.1056/NEJMoa0802905
4. Saez-Cirion A., Bacchus C., Hocqueloux L., Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathogens 2013 9 3 e1003211
5. Sugarman J., HIV cure research: expanding the ethical considerations. Annals of Internal Medicine 2013 10.7326/0003-4819-159-7-201310010-00694
6. Peters B., Post F., Wierzbicki A., Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach. HIV Medicine 2013 14 supplement 1 1 11 10.1111/j.1468-1293.2012.01055.x
7. Stone B., Dockrell D., Bowman C., McCloskey E., HIV and bone disease. Archives of Biochemistry and Biophysics 2010 503 1 66 77 2-s2.0-77956874907 10.1016/j.abb.2010.07.029
8. Guerri-Fernandez R., Vestergaard P., Carbonell C., HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study. Journal of Bone and Mineral Research 2013 28 6 1259 1263
9. Caplan A. I., Mesenchymal stem cells. Journal of Orthopaedic Research 1991 9 5 641 650 2-s2.0-0026228558
10. Yamaguchi A., Komori T., Suda T., Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocrine Reviews 2000 21 4 393 411 2-s2.0-0034455051 10.1210/er.21.4.393 (Pubitemid 32275586)
11. Li Y.-L., Xiao Z.-S., Advances in Runx2 regulation and its isoforms. Medical Hypotheses 2006 68 1 169 175 2-s2.0-33751103183 10.1016/j.mehy.2006.06. 006 (Pubitemid 44767610)
12. Tou L., Quibria N., Alexander J. M., Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7. Molecular and Cellular Endocrinology 2003 205 1-2 121 129 2-s2.0-0142029486 10.1016/S0303-7207(03)00151-5 (Pubitemid 37297358)
13. Jeon E.-J., Lee K.-Y., Choi N.-S., Lee M.-H., Kim H.-N., Jin Y.-H., Ryoo H.-M., Choi J.-Y., Yoshida M., Nishino N., Oh B.-C., Lee K.-S., Yong H. L., Bae S.-C., Bone morphogenetic protein-2 stimulates Runx2 acetylation. Journal of Biological Chemistry 2006 281 24 16502 16511 2-s2.0-33745196250 10.1074/jbc.M512494200
14. Mbalaviele G., Sheikh S., Stains J. P., Salazar V. S., Cheng S.-L., Chen D., Civitelli R., β -catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. Journal of Cellular Biochemistry 2005 94 2 403 418 2-s2.0-17144373190 10.1002/jcb.20253 (Pubitemid 41420317)
15. Sinha K. M., Zhou X., Genetic and molecular control of osterix in skeletal formation. Journal of Cellular Biochemistry 2013 114 5 975 984 10.1002/jcb.24439
16. Hogan B. L. M., Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes and Development 1996 10 13 1580 1594 2-s2.0-0029737070 (Pubitemid 26268864)
17. Massague J., How cells read TGF-beta signals. Nature Reviews Molecular Cell Biology 2000 1 169 178
18. Massagué J., Chen Y.-G., Controlling TGF- β signaling. Genes and Development 2000 14 6 627 644 2-s2.0-0034654497
19. Miyazono K., ten Dijke P., Heldin C.-H., TGF- β signaling by Smad proteins. Advances in Immunology 2000 75 115 157 2-s2.0-0033932667
20. Wang X., Kua H.-Y., Hu Y., Guo K., Zeng Q., Wu Q., Ng H.-H., Karsenty G., De Crombrugghe B., Yeh J., Li B., p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. Journal of Cell Biology 2006 172 1 115 125 2-s2.0-29944437296 10.1083/jcb.200507106 (Pubitemid 43042634)
21. Nohe A., Keating E., Knaus P., Petersen N. O., Signal transduction of bone morphogenetic protein receptors. Cellular Signalling 2004 16 3 291 299 2-s2.0-0346996450 10.1016/j.cellsig.2003.08.011 (Pubitemid 37542404)
22. Gregory C. A., Prockop D. J., Spees J. L., Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Experimental Cell Research 2005 306 2 330 335 2-s2.0-19544377964 10.1016/j.yexcr.2005.03.018 (Pubitemid 40732757)
23. Nuttall M. E., Gimble J. M., Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Current Opinion in Pharmacology 2004 4 3 290 294 2-s2.0-2342613539 10.1016/j.coph.2004.03.002 (Pubitemid 38585315)
24. Meunier P., Aaron J., Edouard C., Vignon G., Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clinical Orthopaedics and Related Research 1971 80 147 154 2-s2.0-0015137446
25. Hartmann C., A Wnt canon orchestrating osteoblastogenesis. Trends in Cell Biology 2006 16 3 151 158 2-s2.0-33644828002 10.1016/j.tcb.2006.01.001 (Pubitemid 43358003)
26. Hill T. P., Später D., Taketo M. M., Birchmeier W., Hartmann C., Canonical Wnt/ β -catenin signaling prevents osteoblasts from differentiating into chondrocytes. Developmental Cell 2005 8 5 727 738 2-s2.0-17844363974 10.1016/j.devcel.2005.02.013 (Pubitemid 40585295)
27. Day T. F., Guo X., Garrett-Beal L., Yang Y., Wnt/ β -catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Developmental Cell 2005 8 5 739 750 2-s2.0-17844372752 10.1016/j.devcel.2005.03.016 (Pubitemid 40585296)
28. Hu H., Hilton M. J., Tu X., Yu K., Ornitz D. M., Long F., Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 2005 132 1 49 60 2-s2.0-13444302715 10.1242/dev.01564 (Pubitemid 40207966)
29. Glass D. A. II, Bialek P., Ahn J. D., Starbuck M., Patel M. S., Clevers H., Taketo M. M., Long F., McMahon A. P., Lang R. A., Karsenty G., Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Developmental Cell 2005 8 5 751 764 2-s2.0-20244373613 10.1016/j.devcel.2005.02. 017 (Pubitemid 40585297)
30. Holmen S. L., Zylstra C. R., Mukherjee A., Sigler R. E., Faugere M.-C., Bouxsein M. L., Deng L., Clemens T. L., Williams B. O., Essential role of β -catenin in postnatal bone acquisition. Journal of Biological Chemistry 2005 280 22 21162 21168 2-s2.0-20444376156 10.1074/jbc.M501900200 (Pubitemid 40805677)
31. Jackson A., Vayssière B., Garcia T., Newell W., Baron R., Roman-Roman S., Rawadi G., Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone 2005 36 4 585 598 2-s2.0-18044393642 10.1016/j.bone.2005. 01.007 (Pubitemid 40602252)
32. Spencer G. J., Utting J. C., Etheridge S. L., Arnett T. R., Genever P. G., Wnt signalling in osteoblasts regulates expression of the receptor activator of NF B ligand and inhibits osteoclastogenesis in vitro. Journal of Cell Science 2006 119 7 1283 1296 2-s2.0-33646808104 10.1242/jcs.02883
33. Logan C. Y., Nusse R., The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 2004 20 781 810 2-s2.0-8444251784 10.1146/annurev.cellbio.20.010403.113126 (Pubitemid 39488658)
34. van Wijnen A. J., van de Peppel J., van Leeuwen J. P., MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Current Osteoporosis Reports 2013 11 2 72 82 10.1007/s11914-013-0143-6
35. Gong Y., Slee R. B., Fukai N., Rawadi G., Roman-Roman S., Reginato A. M., Wang H., Cundy T., Glorieux F. H., Lev D., Zacharin M., Oexle K., Marcelino J., Suwairi W., Heeger S., Sabatakos G., Apte S., Adkins W. N., Allgrove J., Arslan-Kirchner M., Batch J. A., Beighton P., Black G. C. M., Boles R. G., Boon L. M., Borrone C., Brunner H. G., Carle G. F., Dallapiccola B., De Paepe A., Floege B., Halfhide M. L., Hall B., Hennekam R. C., Hirose T., Jans A., Jüppner H., Kim C. A., Keppler-Noreuil K., Kohlschuetter A., LaCombe D., Lambert M., Lemyre E., Letteboer T., Peltonen L., Ramesar R. S., Romanengo M., Somer H., Steichen-Gersdorf E., Steinmann B., Sullivan B., Superti-Furga A., Swoboda W., Van den Boogaard M.-J., Van Hul W., Vikkula M., Votruba M., Zabel B., Garcia T., Baron R., Olsen B. R., Warman M. L., LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001 107 4 513 523 2-s2.0-18044386744 10.1016/S0092-8674(01)00571-2 (Pubitemid 33152786)
36. Karsenty G., Wagner E. F., Reaching a genetic and molecular understanding of skeletal development. Developmental Cell 2002 2 4 389 406 2-s2.0-0036225281 10.1016/S1534-5807(02)00157-0 (Pubitemid 34436569)
37. Boyle W. J., Simonet W. S., Lacey D. L., Osteoclast differentiation and activation. Nature 2003 423 6937 337 342 2-s2.0-0037673945 10.1038/nature01658 (Pubitemid 40852708)
38. Hsu H., Lacey D. L., Dunstan C. R., Solovyev I., Colombero A., Timms E., Tan H.-L., Elliott G., Kelley M. J., Sarosi I., Wang L., Xia X.-Z., Elliott R., Chiu L., Black T., Scully S., Capparelli C., Morony S., Shimamoto G., Bass M. B., Boyle W. J., Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proceedings of the National Academy of Sciences of the United States of America 1999 96 7 3540 3545 2-s2.0-13044316551 10.1073/pnas.96.7.3540 (Pubitemid 29168945)
39. Phan T. C. A., Xu J., Zheng M. H., Interaction between osteoblast and osteoclast: impact in bone disease. Histology and Histopathology 2004 19 4 1325 1344 2-s2.0-6344226562 (Pubitemid 39386790)
40. Fuller K., Wong B., Fox S., Choi Y., Chambers T. J., TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. Journal of Experimental Medicine 1998 188 5 997 1001 2-s2.0-0032494113 10.1084/jem.188.5.997 (Pubitemid 28433427)
41. Sugatani T., Hruska K. A., Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosis. Journal of Cellular Biochemistry 2013 114 6 1217 1222 10.1002/jcb.24471
42. Hassan M. Q., Maeda Y., Taipaleenmaki H., miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. The Journal of Biological Chemistry 2012 287 50 42084 42092
43. Cheng P., Chen C., He H. B., miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. Journal of Bone and Mineral Research 2013 28 5 1180 1190 10.1002/jbmr.1845
44. Troen B. R., Molecular mechanisms underlying osteoclast formation and activation. Experimental Gerontology 2003 38 6 605 614 2-s2.0-0037566322 10.1016/S0531-5565(03)00069-X (Pubitemid 36694163)
45. Hofbauer L. C., Khosla S., Dunstan C. R., Lacey D. L., Spelsberg T. C., Riggs B. L., Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 1999 140 9 4367 4370 2-s2.0-0033304632 (Pubitemid 30647136)
46. Khosla S., Atkinson E. J., Dunstan C. R., O'Fallon W. M., Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. Journal of Clinical Endocrinology and Metabolism 2002 87 4 1550 1554 2-s2.0-0036280935 10.1210/jc.87.4.1550 (Pubitemid 34615237)
47. Shevde N. K., Bendixen A. C., Dienger K. M., Pike J. W., Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proceedings of the National Academy of Sciences of the United States of America 2000 97 14 7829 7834 2-s2.0-0034608813 10.1073/pnas.130200197 (Pubitemid 30460733)
48. Srivastava S., Toraldo G., Weitzmann M. N., Cenci S., Ross F. P., Pacifici R., Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. Journal of Biological Chemistry 2001 276 12 8836 8840 2-s2.0-0035937747 10.1074/jbc.M010764200
49. Srivastava S., Weitzmann M. N., Cenci S., Ross F. P., Adler S., Pacifici R., Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. The Journal of Clinical Investigation 1999 104 4 503 513 2-s2.0-0032694582 (Pubitemid 29534334)
50. Zaidi M., Blair H. C., Moonga B. S., Abe E., Huang C. L.-H., Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. Journal of Bone and Mineral Research 2003 18 4 599 609 2-s2.0-0041304833 (Pubitemid 36899309)
51. Ambros V., Chen X., The regulation of genes and genomes by small RNAs. Development 2007 134 9 1635 1641 2-s2.0-34249076321 10.1242/dev.002006 (Pubitemid 46796561)
52. Cullen B. R., Transcription and processing of human microRNA precursors. Molecular Cell 2004 16 6 861 865 2-s2.0-10944254152 10.1016/j.molcel.2004.12.002 (Pubitemid 40018397)
53. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., Sharon E., Spector Y., Bentwich Z., Identification of hundreds of conserved and nonconserved human microRNAs. Nature Genetics 2005 37 7 766 770 2-s2.0-22844440427 10.1038/ng1590 (Pubitemid 41754896)
54. Lee Y., Jeon K., Lee J.-T., Kim S., Kim V. N., MicroRNA maturation: stepwise processing and subcellular localization. The EMBO Journal 2002 21 17 4663 4670 2-s2.0-0037009364 10.1093/emboj/cdf476 (Pubitemid 34984353)
55. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T., Identification of novel genes coding for small expressed RNAs. Science 2001 294 5543 853 858 2-s2.0-0035955374 10.1126/science.1064921 (Pubitemid 33032103)
56. Mizuno Y., Tokuzawa Y., Ninomiya Y., Yagi K., Yatsuka-Kanesaki Y., Suda T., Fukuda T., Katagiri T., Kondoh Y., Amemiya T., Tashiro H., Okazaki Y., miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Letters 2009 583 13 2263 2268 2-s2.0-67649381623 10.1016/j.febslet.2009.06.006
57. Mizuno Y., Yagi K., Tokuzawa Y., Kanesaki-Yatsuka Y., Suda T., Katagiri T., Fukuda T., Maruyama M., Okuda A., Amemiya T., Kondoh Y., Tashiro H., Okazaki Y., miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochemical and Biophysical Research Communications 2008 368 2 267 272 2-s2.0-39549105164 10.1016/j.bbrc.2008.01.073
58. Luzi E., Marini F., Sala S. C., Tognarini I., Galli G., Brandi M. L., Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. Journal of Bone and Mineral Research 2008 23 2 287 295 2-s2.0-38549101581 10.1359/jbmr.071011 (Pubitemid 351160043)
59. Li Z., Hassan M. Q., Volinia S., Van Wijnen A. J., Stein J. L., Croce C. M., Lian J. B., Stein G. S., A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proceedings of the National Academy of Sciences of the United States of America 2008 105 37 13906 13911 2-s2.0-52949114558 10.1073/pnas.0804438105
60. Huang J., Zhao L., Xing L., Chen D., MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010 28 2 357 364 2-s2.0-77149136767 10.1002/stem.288
61. Kapinas K., Kessler C. B., Delany A. M., miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. Journal of Cellular Biochemistry 2009 108 1 216 224 2-s2.0-69249143283 10.1002/jcb.22243
62. Itoh T., Nozawa Y., Akao Y., MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. Journal of Biological Chemistry 2009 284 29 19272 19279 2-s2.0-67749145694 10.1074/jbc.M109.014001
63. Li H., Xie H., Liu W., Hu R., Huang B., Tan Y.-F., Liao E.-Y., Xu K., Sheng Z.-F., Zhou H.-D., Wu X.-P., Luo X.-H., A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. The Journal of Clinical Investigation 2009 119 12 3666 3677 2-s2.0-72849121740 10.1172/JCI39832
64. Hu R., Liu W., Li H., Yang L., Chen C., Xia Z.-Y., Guo L.-J., Xie H., Zhou H.-D., Wu X.-P., Luo X.-H., A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. Journal of Biological Chemistry 2011 286 14 12328 12339 2-s2.0-79953327693 10.1074/jbc.M110.176099
65. Mori M., Nakagami H., Rodriguez-Araujo G., Nimura K., Kaneda Y., Essential role for miR-196a in brown adipogenesis of white fat progenitor cells. PLoS Biology 2012 10 4 2-s2.0-84860009214 10.1371/journal.pbio.1001314 e1001314
66. Tomé M., López-Romero P., Albo C., Seplveda J. C., Fernández-Gutiérrez B., Dopazo A., Bernad A., González M. A., miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death and Differentiation 2011 18 6 985 995 2-s2.0-79955805703 10.1038/cdd.2010.167
67. Zhang J., Tu Q., Bonewald L. F., He X., Stein G., Lian J., Chen J., Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. Journal of Bone and Mineral Research 2011 26 8 1953 1963 2-s2.0-79960633240 10.1002/jbmr.377
68. Schaap-Oziemlak A. M., Raymakers R. A., Bergevoet S. M., Gilissen C., Jansen B. J. H., Adema G. J., Kögler G., Sage C. L., Agami R., Van Der Reijden B. A., Jansen J. H., MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells. Stem Cells and Development 2010 19 6 877 885 2-s2.0-77954209607 10.1089/scd.2009.0112
69. Li Z., Hassan M. Q., Jafferji M., Aqeilan R. I., Garzon R., Croce C. M., van Wijnen A. J., Stein J. L., Stein G. S., Lian J. B., Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. Journal of Biological Chemistry 2009 284 23 15676 15684 2-s2.0-67650169908 10.1074/jbc.M809787200
70. Eskildsen T., Taipaleenmäki H., Stenvang J., Abdallah B. M., Ditzel N., Nossent A. Y., Bak M., Kauppinen S., Kassem M., MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proceedings of the National Academy of Sciences of the United States of America 2011 108 15 6139 6144 2-s2.0-79955016827 10.1073/pnas.1016758108
71. Zhang J.-F., Fu W.-M., He M.-L., Xie W.-D., Lv Q., Wan G., Li G., Wang H., Lu G., Hu X., Jiang S., Li J.-N., Lin M. C. M., Zhang Y.-O., Kung H.-F., MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biology 2011 8 5 829 838 2-s2.0-80052786029
72. Zhang J.-F., Fu W.-M., He M.-L., Wang H., Wang W.-M., Yu S.-C., Bian X.-W., Zhou J., Lin M. C. M., Lu G., Poon W.-S., Kung H.-F., MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Molecular Biology of the Cell 2011 22 21 3955 3961 2-s2.0-80655125005 10.1091/mbc.E11-04-0356
73. Laine S. K., Alm J. J., Virtanen S. P., Aro H. T., Laitala-Leinonen T. K., MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells. Journal of Cellular Biochemistry 2012 113 8 2687 2695 10.1002/jcb.24144
74. Suomi S., Taipaleenmäki H., Seppänen A., Ripatti T., Väänänen K., Hentunen T., Säämänen A.-M., Laitala-Leinonen T., MicroRNAs regulate osteogenesis and chondrogenesis of mouse bone marrow stromal cells. Gene Regulation and Systems Biology 2008 2 177 191 2-s2.0-77953436610 (Pubitemid 351722457)
75. Sugatani T., Vacher J., Hruska K. A., A microRNA expression signature of osteoclastogenesis. Blood 2011 117 13 3648 3657 2-s2.0-79953686494 10.1182/blood-2010-10-311415
76. Zhu L. Y., Qiu C., Lv J. X., Xu J. Q., HIV-1 infection changes miRNA expression profile in the whole blood. Bing Du Xue Bao 2013 29 3 323 329
77. Raaijmakers M. H. G. P., Mukherjee S., Guo S., Zhang S., Kobayashi T., Schoonmaker J. A., Ebert B. L., Al-Shahrour F., Hasserjian R. P., Scadden E. O., Aung Z., Matza M., Merkenschlager M., Lin C., Rommens J. M., Scadden D. T., Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010 464 7290 852 857 2-s2.0-77950862042 10.1038/nature08851
78. Sugatani T., Hruska K. A., Impaired micro-RNA pathways diminish osteoclast differentiation and function. Journal of Biological Chemistry 2009 284 7 4667 4678 2-s2.0-63249113375 10.1074/jbc.M805777200
79. Sugatani T., Hruska K. A., MicroRNA-223 is a key factor in osteoclast differentiation. Journal of Cellular Biochemistry 2007 101 4 996 999 2-s2.0-34447262870 10.1002/jcb.21335 (Pubitemid 47040879)
80. Wang Y., Li L., Moore B. T., Peng X.-H., Fang X., Lappe J. M., Recker R. R., Xiao P., Mir-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS ONE 2012 7 4 2-s2.0-84859595006 10.1371/journal.pone.0034641 e34641
81. Yin M. T., Zhang C. A., McMahon D. J., Ferris D. C., Irani D., Colon I., Cremers S., Shane E., Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study. Journal of Clinical Endocrinology and Metabolism 2012 97 2 554 562 2-s2.0-84856769335 10.1210/jc.2011-2197
82. Cazanave C., Dupon M., Lavignolle-Aurillac V., Barthe N., Lawson-Ayayi S., Mehsen N., Mercié P., Morlat P., Thiébaut R., Dabis F., Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. AIDS 2008 22 3 395 402 2-s2.0-38149084061 10.1097/QAD.0b013e3282f423dd
83. + postmenopausal women. Osteoporosis International 2005 16 11 1345 1352 2-s2.0-27544509496 10.1007/s00198-005-1845-0 (Pubitemid 41534646)
84. Jones S., Restrepo D., Kasowitz A., Korenstein D., Wallenstein S., Schneider A., Keller M. J., Risk factors for decreased bone density and effects of HIV on bone in the elderly. Osteoporosis International 2008 19 7 913 918 2-s2.0-44649084952 10.1007/s00198-007-0524-8
85. Carr A., Miller J., Eisman J. A., Cooper D. A., Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS 2001 15 6 703 709 2-s2.0-0035853371 10.1097/00002030-200104130-00005 (Pubitemid 32423217)
86. Amiel C., Ostertag A., Slama L., Baudoin C., N'Guyen T., Lajeunie E., Neit-Ngeilh L., Rozenbaum W., De Vernejoul M. C., BMD is reduced in HIV-infected men irrespective of treatment. Journal of Bone and Mineral Research 2004 19 3 402 409 2-s2.0-2942724686 10.1359/JBMR.0301246 (Pubitemid 38787395)
87. Mondy K., Yarasheski K., Powderly W. G., Whyte M., Claxton S., DeMarco D., Hoffmann M., Tebas P., Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clinical Infectious Diseases 2003 36 4 482 490 2-s2.0-0037442930 10.1086/367569 (Pubitemid 36241317)
88. Gibellini D., de Crignis E., Ponti C., Cimatti L., Borderi M., Tschon M., Giardino R., Re M. C., HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNF α activation. Journal of Medical Virology 2008 80 9 1507 1514 2-s2.0-48249097085 10.1002/jmv.21266
89. Amorosa V., Tebas P., Bone disease and HIV infection. Clinical Infectious Diseases 2006 42 1 108 114 2-s2.0-29244465093 10.1086/498511 (Pubitemid 41832089)
90. Pan G., Kilby M., McDonald J. M., Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors. AIDS Research and Human Retroviruses 2006 22 11 1131 1141 2-s2.0-33845442342 10.1089/aid.2006.22.1131 (Pubitemid 44904264)
91. Gibellini D., Borderi M., de Crignis E., Cicola R., Vescini F., Caudarella R., Chiodo F., Re M. C., RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men. Journal of Medical Virology 2007 79 10 1446 1454 2-s2.0-34548280376 10.1002/jmv.20938 (Pubitemid 47328732)
92. Wei S., Kitaura H., Zhou P., Patrick Ross F., Teitelbaum S. L., IL-1 mediates TNF-induced osteoclastogenesis. The Journal of Clinical Investigation 2005 115 2 282 290 2-s2.0-14944371405 10.1172/JCI200523394 (Pubitemid 40385470)
93. Fakruddin J. M., Laurence J., HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk. Journal of Biological Chemistry 2003 278 48 48251 48258 2-s2.0-0348111447 10.1074/jbc.M304676200 (Pubitemid 37523280)
94. Fakruddin J. M., Laurence J., HIV-1 Vpr enhances production of receptor of activated NF- B ligand (RANKL) via potentiation of glucocorticoid receptor activity. Archives of Virology 2005 150 1 67 78 2-s2.0-12944281565 10.1007/s00705-004-0395-7 (Pubitemid 40171950)
95. Herbeuval J.-P., Boasso A., Grivel J.-C., Hardy A. W., Anderson S. A., Dolan M. J., Chougnet C., Lifson J. D., Shearer G. M., TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 2005 105 6 2458 2464 2-s2.0-15244358107 10.1182/blood-2004-08-3058 (Pubitemid 40387046)
96. + cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. Journal of Virology 2003 77 12 6700 6708 2-s2.0-0038618970 10.1128/JVI.77.12.6700-6708.2003 (Pubitemid 36666864)
97. Wong B. R., Besser D., Kim N., Arron J. R., Vologodskaia M., Hanafusa H., Choi Y., TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Molecular Cell 1999 4 6 1041 1049 2-s2.0-0033393957 (Pubitemid 30054909)
98. Pan G., Yang Z., Ballinger S. W., McDonald J. M., Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS. Annals of the New York Academy of Sciences 2006 1068 1 297 308 2-s2.0-33744762135 10.1196/annals.1346.057 (Pubitemid 43824161)
99. Salmena L., Poliseno L., Tay Y., Kats L., Pandolfi P. P., A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell 2011 146 3 353 358 2-s2.0-79961170994 10.1016/j.cell.2011.07.014
100. + T cell line. mBio 2011 2 5 2-s2.0-84855911746 10.1128/mBio.00134-11
101. + T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. Virology 2012 429 1 37 46 2-s2.0-84859930332 10.1016/j.virol.2012.03.026
102. Yeung M. L., Bennasser Y., Myers T. G., Jiang G., Benkirane M., Jeang K.-T., Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology 2005 2, article 81 2-s2.0-30344465007 10.1186/1742-4690-2-81 (Pubitemid 43055756)
103. Houzet L., Yeung M. L., de Lame V., Desai D., Smith S. M., Jeang K.-T., MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 2008 5, article 118 2-s2.0-61349100846 10.1186/1742-4690-5-118
104. Chang S. T., Thomas M. J., Sova P., Green R. R., Palermo R. E., Katze M. G., Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection. mBio 2013 4 1 10.1128/mBio.00549-12